Peer Review History
| Original SubmissionAugust 13, 2020 |
|---|
|
PONE-D-20-25338 Changes in visual attentional behavior in complex regional pain syndrome PLOS ONE Dear Dr. Ushida, Thank you for submitting your manuscript to PLOS ONE. It has been thoroughly reviewed by two experts in the field and, after careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the comments raised during the review process. Both reviewers have supplied useful lists of points at which more detail could be included. In some places this is to ensure clarity, and to disambiguate content, whereas in other places it to fully elaborate on assertions that have been made in the text. I encourage you to address all of these comments to the best of your abilities, as they will certainly help your submission to maximise its potential impact. Please submit your revised manuscript by Nov 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Alastair D. Smith Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting study. I have only a few minor comments Lines 62/63. Another recent study by Halicka et al (2020), published in Cortex, also found no significant evidence of visual attention bias in a large group of patients over a broad battery of tests. Similarly on line 264 Lines 65/66. This appears to be part of the rationale of the study, however it could do with rewording. Responses to visual perception tasks ARE behaviour. I think I can see what the authors mean, but they should choose different wording to express how their study differs. Perhaps something like “visual exploration of a scene” or “overt visual exploration” would be appropriate. Lines 71-78. It’s not clear how the use of eye tracking allowed insights into attention in these studies, so the authors should make this explicit. Presumably there were differences in the participants’ looking behaviour (gaze duration etc). Lines 318-319. It is quite likely that the absence of significant correlations could be due to the small sample size in this study. Data should be shared as supplementary material to the paper, or uploaded to a public repository. Reviewer #2: This study adds an interesting and novel idea for assessing pathophysiological changes in CRPS. This paper would, however, benefit greatly from some language editing and restructuring as the manner and extent of differences between healthy controls and patients discovered is quite hard to understand. The number of participants was quite low and the variety of inciting events of CRPS was high. The effort to match controls in age and gender and the fact that only patients with CRPS type 1 in the upper limb with the same dominant hand have been included aids the quality of the study. Nevertheless the low number of participants should clearly be stated as a limitation. I therefore suggest adding „a preliminary study“ to the titel. Introduction: lls 64: „Furthermore, most studies of spatial bias in CRPS have assessed responses to the task…“ The meaning of this sentence is unclear. Please clarify. Material and methods Please state, which limb was affected. The affected hand being the dominant one could influence the results. The section Pain and other clinical evaluations requires some more structure. Especially the part regarding the HADS is not clear. Please explain how the cut-off can be 10/11, when 21 points can be reached on each subscale. ll 108: „Cut-off for chronic pain was 10 points in Japanese“ The meaning of this sentence is unclear. Please clarify. lls 142: Please define fixation count and fixation duration using complete sentences. Figure 1: Please explain how „nonspecific neck shoulder pain“ is an inciting event for CRPS. There is quite the variety in inciting events (contusion of upper limb to blood sampling). Please add this to the limitations! Results The results section in general requires more structure. It is not always clear which side is being referred to. For example: Is „the painful side“ referring to the side of the person in the video corresponding tot he painful side of the patient? This is especially important as you refer to this in your discussion, but it is hard to understand the parts of the results section you are referring to. lls 199: „In contrast, CRPS patients showed significant differences in FDs on the face and both forearms, and in FCs on the face and nonpainful forearm (p< 0.05, Table 2), but not in FDs and FCs on the face and body.“ Please state how these were different. Were they higher or lower? lls 210: „Other clinical parameters, such as pain intensity, disability, disease duration, and psychological state (PCS, HADS) did not show any association with the eye-movement data.“ Does this mean no correlation? Discussion: Could the change of visual attention be explained by a painful disorder of the upper extremity in general and therefore not be specific to CRPS? Please discuss this. An additional control group with a non-CRPS painful disorder oft he upper extremity could have been added. Please add this tot he limitations. „However, this study showed that the visual attention on faces tended to be lower in CRPS patients than in healthy controls. In particular, this tendency was found in patients with low body cognitive distortions.“ (ll 255) How do you explain this. Please discuss. Please discuss, why the forearm seemed to play a bigger role than the hand. Was the forearm affected in a majority of your patients? The number of participants was very low and as you stated eye movement varies greately between individuals. How much variation was there between healthy individuals? You did not find the same association between neglect-like symptoms (or the eye-tracking parameters you hypothesise might be assosciated with those) as Sumitani et al. Please discuss why this might be. Please discuss possible social disadvantages you state might occure for CRPS patients. Are there previous studies reporting those? Minor ll 48: superfluous space after hyperalgesia ll 79: „also would have not only changes in special attention“ -> Do you mean „spacial“? ll 110: „the exaggeration of pain“ -> Please consider rephrasing. ll 110: superfluous komma after anxiety ll 123: please explain the abbreviation TFT ll 126 „Eye-tracking glasses are equipped…“ Please stay consistent using past tense. lls 241: „Note that healthy control gazed at the face in Video 1 (Fig. 6E) and not gazed at the hand before being touched in Video 2 (Fig. 6F).“ -> did not gaze lls 272: „and visual attention for face“ for the face ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Janet H Bultitude Reviewer #2: Yes: Ralf Baron [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-25338R1 Changes in visual attentional behavior in complex regional pain syndrome: A preliminary study PLOS ONE Dear Dr. Ushida, Thank you for submitting your manuscript to PLOS ONE. It has been looked over by the reviewers and they are broadly satisfied that their comments have been appropriately addressed. As such, I would like to think that we may be close to accepting the manuscript. However, you will see that (alongside a couple of minor points) Reviewer 2 still feels that the Discussion could be better structured. I am in agreement here - the section would benefit from a clearer narrative and, whilst I am usually unsure about the utility of subheadings, it may be that the inclusion of some will help you to organise the themes in a more approachable fashion. I also echo the recommendation that the manuscript is thoroughly reviewed for correct English - this is the last opportunity for the document to be fully ratified for language, and so a final proofing would be advised. We invite you to submit a revised version of the manuscript that addresses these points. Upon receipt, I shall then decide whether the manuscript can be accepted as is, or whether another review round is appropriate. Please submit your revised manuscript by Mar 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Alastair D. Smith Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Thank you for considering the remarks. The manuscript improved greatly. Please rephrase: ll73: Depressed participants paid more attention (i.e. increased fixation duration) to sad faces significantly more than healthy controls. l 102 and 105: The sentence “All participants provided written informed consent prior to participation in this study.“ appears twice l 273 “it was reported that visual attentional bias for faces IS reduced in depressed individuals” Please consider further structuring of the discussion as it remains hard to read. Consider adding subheadings for added clarity. Please check thoroughly for language errors! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Changes in visual attentional behavior in complex regional pain syndrome: A preliminary study PONE-D-20-25338R2 Dear Dr. Ushida, Many thanks for submitting your revised manuscript. We’re pleased to inform you that it has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Alastair D. Smith Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-20-25338R2 Changes in visual attentional behavior in complex regional pain syndrome: A preliminary study Dear Dr. Ushida: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Alastair Smith Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .